Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Adrenergic signaling in cardiomyocytes
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬1. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||
| 2 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Adrenergic signaling in cardiomyocytes
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬1. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||
| 3 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
AGTR1 [1] AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Adrenergic signaling in cardiomyocytes
| Valsartan | 028 [11] 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬3. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||
| 4 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Adrenergic signaling in cardiomyocytes |
Digoxin Digoxin 💬Adrenergic signaling in cardiomyocytes
| Digoxin | 002 [7] 2 , 8 , 46, 57, 65, 67, 210 💬4. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||
| 5 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 58 drugs (DrugBank) and 100 diseases |
AGTR1 [1] AGTR1 💬AGE-RAGE signaling pathway in diabetic complications
|
Valsartan Valsartan 💬AGE-RAGE signaling pathway in diabetic complications
| Valsartan | 028 [11] 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬5. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||
| 6 | Aldosterone synthesis and secretion 💬 20 genes, 43 drugs (DrugBank) and 63 diseases |
AGTR1 [1] AGTR1 💬Aldosterone synthesis and secretion
|
Valsartan Valsartan 💬Aldosterone synthesis and secretion
| Valsartan | 028 [11] 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬6. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 7 | Aldosterone synthesis and secretion 💬 20 genes, 43 drugs (DrugBank) and 63 diseases |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Aldosterone synthesis and secretion |
Digoxin Digoxin 💬Aldosterone synthesis and secretion
| Digoxin | 002 [7] 2 , 8 , 46, 57, 65, 67, 210 💬7. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 8 | Aldosterone-regulated sodium reabsorption 💬 13 genes, 17 drugs (DrugBank) and 34 diseases |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Aldosterone-regulated sodium reabsorption |
Digoxin Digoxin 💬Aldosterone-regulated sodium reabsorption
| Digoxin | 002 [7] 2 , 8 , 46, 57, 65, 67, 210 💬8. Aldosterone-regulated sodium reabsorption
|
||||||||||||||||||||||||||||||||||||||||||||
| 9 | Aldosterone-regulated sodium reabsorption 💬 13 genes, 17 drugs (DrugBank) and 34 diseases |
NR3C2 [1] NR3C2 💬Aldosterone-regulated sodium reabsorption
|
Eplerenone Eplerenone 💬Aldosterone-regulated sodium reabsorption
| Eplerenone | 057 [5] 57, 75, 113, 210, 215 💬9. Aldosterone-regulated sodium reabsorption
|
||||||||||||||||||||||||||||||||||||||||||||
| 10 | Aldosterone-regulated sodium reabsorption 💬 13 genes, 17 drugs (DrugBank) and 34 diseases |
NR3C2 [1] NR3C2 💬Aldosterone-regulated sodium reabsorption
|
Spironolactone Spironolactone 💬Aldosterone-regulated sodium reabsorption
| Spironolactone | 046 [12] 46, 57, 58, 67, 86, 113, 210, 214, 218, 222, 223, 225 💬10. Aldosterone-regulated sodium reabsorption
|
||||||||||||||||||||||||||||||||||||||||||||
| 11 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
MME [1] MME 💬Alzheimer disease
|
Sacubitril Sacubitril 💬Alzheimer disease
| Sacubitril | 028 [4] 28, 58, 210, 222 💬11. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||
| 12 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
PTGS2 [1] PTGS2 💬Alzheimer disease
|
Aspirin Aspirin 💬Alzheimer disease
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬12. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||
| 13 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Alzheimer disease
|
Colchicine Colchicine 💬Alzheimer disease
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬13. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||
| 14 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
ADRA1A [1] ADRA1A 💬AMPK signaling pathway
|
Carvedilol Carvedilol 💬AMPK signaling pathway
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬14. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 15 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
ADRA1A [1] ADRA1A 💬AMPK signaling pathway
|
Carvedilol phosphate Carvedilol phosphate 💬AMPK signaling pathway
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬14. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 16 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Pravastatin sodium Pravastatin sodium 💬AMPK signaling pathway
| Pravastatin | 013 [11] 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬16. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 17 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Pravastatin Pravastatin 💬AMPK signaling pathway
| Pravastatin | 013 [11] 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬16. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 18 | Amyotrophic lateral sclerosis 💬 39 genes, 58 drugs (DrugBank) and 116 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Amyotrophic lateral sclerosis
|
Colchicine Colchicine 💬Amyotrophic lateral sclerosis
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬18. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||||||
| 19 | Apelin signaling pathway 💬 18 genes, 37 drugs (DrugBank) and 81 diseases |
AGTR1 [1] AGTR1 💬Apelin signaling pathway
|
Valsartan Valsartan 💬Apelin signaling pathway
| Valsartan | 028 [11] 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬19. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 20 | Arachidonic acid metabolism 💬 5 genes, 29 drugs (DrugBank) and 46 diseases |
PTGS1 [2] PTGS1, PTGS2 💬
|
Aspirin Aspirin 💬Arachidonic acid metabolism
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬20. Arachidonic acid metabolism
|
||||||||||||||||||||||||||||||||||||||||||||
| 21 | Bile secretion 💬 13 genes, 36 drugs (DrugBank) and 66 diseases |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Bile secretion |
Digoxin Digoxin 💬Bile secretion
| Digoxin | 002 [7] 2 , 8 , 46, 57, 65, 67, 210 💬21. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 22 | Bile secretion 💬 13 genes, 36 drugs (DrugBank) and 66 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Pravastatin sodium Pravastatin sodium 💬Bile secretion
| Pravastatin | 013 [11] 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬22. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 23 | Bile secretion 💬 13 genes, 36 drugs (DrugBank) and 66 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Pravastatin Pravastatin 💬Bile secretion
| Pravastatin | 013 [11] 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬22. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 24 | C-type lectin receptor signaling pathway 💬 28 genes, 71 drugs (DrugBank) and 108 diseases |
PTGS2 [1] PTGS2 💬C-type lectin receptor signaling pathway
|
Aspirin Aspirin 💬C-type lectin receptor signaling pathway
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬24. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 25 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Calcium signaling pathway
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬25. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 26 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Calcium signaling pathway
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬25. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 27 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
AGTR1 [1] AGTR1 💬Calcium signaling pathway
|
Valsartan Valsartan 💬Calcium signaling pathway
| Valsartan | 028 [11] 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬27. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 28 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
AVPR1A [2] AVPR1A, AVPR1B 💬
|
Vasopressin Vasopressin 💬Calcium signaling pathway
| Vasopressin | 210 [2] 210, 225 💬
|
||||||||||||||||||||||||||||||||||||||||||||
| 29 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
EDNRA [1] EDNRA 💬Calcium signaling pathway
|
Ambrisentan Ambrisentan 💬Calcium signaling pathway
| Ambrisentan | 051 [10] 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬29. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 30 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Calcium signaling pathway
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬30. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 31 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Calcium signaling pathway
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬30. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 32 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Macitentan Macitentan 💬Calcium signaling pathway
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬32. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 33 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ADRB1 [2] ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬cAMP signaling pathway
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬33. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 34 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ADRB1 [2] ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬cAMP signaling pathway
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬33. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 35 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬cAMP signaling pathway |
Digoxin Digoxin 💬cAMP signaling pathway
| Digoxin | 002 [7] 2 , 8 , 46, 57, 65, 67, 210 💬35. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 36 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
EDNRA [1] EDNRA 💬cAMP signaling pathway
|
Ambrisentan Ambrisentan 💬cAMP signaling pathway
| Ambrisentan | 051 [10] 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬36. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 37 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
EDNRA [1] EDNRA 💬cAMP signaling pathway
|
Bosentan Bosentan 💬cAMP signaling pathway
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬37. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 38 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
EDNRA [1] EDNRA 💬cAMP signaling pathway
|
Bosentan Bosentan 💬cAMP signaling pathway
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬37. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 39 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
EDNRA [1] EDNRA 💬cAMP signaling pathway
|
Macitentan Macitentan 💬cAMP signaling pathway
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬39. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 40 | Carbohydrate digestion and absorption 💬 13 genes, 22 drugs (DrugBank) and 40 diseases |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Carbohydrate digestion and absorption |
Digoxin Digoxin 💬Carbohydrate digestion and absorption
| Digoxin | 002 [7] 2 , 8 , 46, 57, 65, 67, 210 💬40. Carbohydrate digestion and absorption
|
||||||||||||||||||||||||||||||||||||||||||||
| 41 | Cardiac muscle contraction 💬 17 genes, 21 drugs (DrugBank) and 34 diseases |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Cardiac muscle contraction |
Digoxin Digoxin 💬Cardiac muscle contraction
| Digoxin | 002 [7] 2 , 8 , 46, 57, 65, 67, 210 💬41. Cardiac muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||
| 42 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬cGMP-PKG signaling pathway
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬42. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 43 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬cGMP-PKG signaling pathway
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬42. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 44 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
AGTR1 [1] AGTR1 💬cGMP-PKG signaling pathway
|
Valsartan Valsartan 💬cGMP-PKG signaling pathway
| Valsartan | 028 [11] 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬44. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 45 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬cGMP-PKG signaling pathway |
Digoxin Digoxin 💬cGMP-PKG signaling pathway
| Digoxin | 002 [7] 2 , 8 , 46, 57, 65, 67, 210 💬45. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 46 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
EDNRA [1] EDNRA 💬cGMP-PKG signaling pathway
|
Ambrisentan Ambrisentan 💬cGMP-PKG signaling pathway
| Ambrisentan | 051 [10] 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬46. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 47 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬cGMP-PKG signaling pathway
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬47. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 48 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬cGMP-PKG signaling pathway
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬47. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 49 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Macitentan Macitentan 💬cGMP-PKG signaling pathway
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬49. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 50 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
PDE5A [1] PDE5A 💬cGMP-PKG signaling pathway
|
Sildenafil citrate Sildenafil citrate 💬cGMP-PKG signaling pathway
| Sildenafil | 006 [17] 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬50. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 51 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
PDE5A [1] PDE5A 💬cGMP-PKG signaling pathway
|
Sildenafil Sildenafil 💬cGMP-PKG signaling pathway
| Sildenafil | 006 [17] 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬50. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 52 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
PDE5A [1] PDE5A 💬cGMP-PKG signaling pathway
|
Tadalafil Tadalafil 💬cGMP-PKG signaling pathway
| Tadalafil | 006 [8] 6 , 51, 75, 77, 84, 86, 113, 210 💬52. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 53 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
PDE5A [1] PDE5A 💬cGMP-PKG signaling pathway
|
Udenafil Udenafil 💬cGMP-PKG signaling pathway
| Udenafil | 086 [2] 86, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||
| 54 | Chagas disease 💬 32 genes, 59 drugs (DrugBank) and 88 diseases |
ACE [1] ACE 💬Chagas disease
|
Enalapril maleate Enalapril maleate 💬Chagas disease
| Enalapril | 013 [10] 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬54. Chagas disease
|
||||||||||||||||||||||||||||||||||||||||||||
| 55 | Chagas disease 💬 32 genes, 59 drugs (DrugBank) and 88 diseases |
ACE [1] ACE 💬Chagas disease
|
Enalapril Enalapril 💬Chagas disease
| Enalapril | 013 [10] 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬54. Chagas disease
|
||||||||||||||||||||||||||||||||||||||||||||
| 56 | Chemical carcinogenesis - DNA adducts 💬 1 gene, 26 drugs (DrugBank) and 43 diseases |
PTGS2 [1] PTGS2 💬Chemical carcinogenesis - DNA adducts
|
Aspirin Aspirin 💬Chemical carcinogenesis - DNA adducts
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬56. Chemical carcinogenesis - DNA adducts
|
||||||||||||||||||||||||||||||||||||||||||||
| 57 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
ADRB1 [2] ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Chemical carcinogenesis - receptor activation
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬57. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||||||||||||
| 58 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
ADRB1 [2] ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Chemical carcinogenesis - receptor activation
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬57. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||||||||||||
| 59 | Complement and coagulation cascades 💬 21 genes, 46 drugs (DrugBank) and 60 diseases |
F10 [1] F10 💬Complement and coagulation cascades
|
Rivaroxaban Rivaroxaban 💬Complement and coagulation cascades
| Rivaroxaban | 046 [10] 46, 48, 49, 56, 58, 75, 91, 210, 222, 271 💬59. Complement and coagulation cascades
|
||||||||||||||||||||||||||||||||||||||||||||
| 60 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
ACE [1] ACE 💬Coronavirus disease
|
Enalapril maleate Enalapril maleate 💬Coronavirus disease
| Enalapril | 013 [10] 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬60. Coronavirus disease
|
||||||||||||||||||||||||||||||||||||||||||||
| 61 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
ACE [1] ACE 💬Coronavirus disease
|
Enalapril Enalapril 💬Coronavirus disease
| Enalapril | 013 [10] 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬60. Coronavirus disease
|
||||||||||||||||||||||||||||||||||||||||||||
| 62 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
AGTR1 [1] AGTR1 💬Coronavirus disease
|
Valsartan Valsartan 💬Coronavirus disease
| Valsartan | 028 [11] 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬62. Coronavirus disease
|
||||||||||||||||||||||||||||||||||||||||||||
| 63 | Cortisol synthesis and secretion 💬 15 genes, 39 drugs (DrugBank) and 63 diseases |
AGTR1 [1] AGTR1 💬Cortisol synthesis and secretion
|
Valsartan Valsartan 💬Cortisol synthesis and secretion
| Valsartan | 028 [11] 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬63. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 64 | Cushing syndrome 💬 23 genes, 56 drugs (DrugBank) and 71 diseases |
AGTR1 [1] AGTR1 💬Cushing syndrome
|
Valsartan Valsartan 💬Cushing syndrome
| Valsartan | 028 [11] 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬64. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||
| 65 | Cytoskeleton in muscle cells 💬 26 genes, 19 drugs (DrugBank) and 17 diseases |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Cytoskeleton in muscle cells |
Digoxin Digoxin 💬Cytoskeleton in muscle cells
| Digoxin | 002 [7] 2 , 8 , 46, 57, 65, 67, 210 💬65. Cytoskeleton in muscle cells
|
||||||||||||||||||||||||||||||||||||||||||||
| 66 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
ACE [1] ACE 💬Diabetic cardiomyopathy
|
Enalapril maleate Enalapril maleate 💬Diabetic cardiomyopathy
| Enalapril | 013 [10] 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬66. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||
| 67 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
ACE [1] ACE 💬Diabetic cardiomyopathy
|
Enalapril Enalapril 💬Diabetic cardiomyopathy
| Enalapril | 013 [10] 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬66. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||
| 68 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
AGTR1 [1] AGTR1 💬Diabetic cardiomyopathy
|
Valsartan Valsartan 💬Diabetic cardiomyopathy
| Valsartan | 028 [11] 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬68. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||
| 69 | Dilated cardiomyopathy 💬 23 genes, 61 drugs (DrugBank) and 93 diseases |
ADRB1 [1] ADRB1 💬Dilated cardiomyopathy
|
Carvedilol Carvedilol 💬Dilated cardiomyopathy
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬69. Dilated cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||
| 70 | Dilated cardiomyopathy 💬 23 genes, 61 drugs (DrugBank) and 93 diseases |
ADRB1 [1] ADRB1 💬Dilated cardiomyopathy
|
Carvedilol phosphate Carvedilol phosphate 💬Dilated cardiomyopathy
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬69. Dilated cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||
| 71 | Efferocytosis 💬 30 genes, 78 drugs (DrugBank) and 97 diseases |
PTGS2 [1] PTGS2 💬Efferocytosis
|
Aspirin Aspirin 💬Efferocytosis
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬71. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||||||
| 72 | Endocrine and other factor-regulated calcium reabsorption 💬 9 genes, 31 drugs (DrugBank) and 50 diseases |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Endocrine and other factor-regulated calcium reabsorption |
Digoxin Digoxin 💬Endocrine and other factor-regulated calcium reabsorption
| Digoxin | 002 [7] 2 , 8 , 46, 57, 65, 67, 210 💬72. Endocrine and other factor-regulated calcium reabsorption
|
||||||||||||||||||||||||||||||||||||||||||||
| 73 | Gap junction 💬 27 genes, 103 drugs (DrugBank) and 87 diseases |
ADRB1 [1] ADRB1 💬Gap junction
|
Carvedilol Carvedilol 💬Gap junction
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬73. Gap junction
|
||||||||||||||||||||||||||||||||||||||||||||
| 74 | Gap junction 💬 27 genes, 103 drugs (DrugBank) and 87 diseases |
ADRB1 [1] ADRB1 💬Gap junction
|
Carvedilol phosphate Carvedilol phosphate 💬Gap junction
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬73. Gap junction
|
||||||||||||||||||||||||||||||||||||||||||||
| 75 | Gap junction 💬 27 genes, 103 drugs (DrugBank) and 87 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Gap junction
|
Colchicine Colchicine 💬Gap junction
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬75. Gap junction
|
||||||||||||||||||||||||||||||||||||||||||||
| 76 | Gastric acid secretion 💬 14 genes, 54 drugs (DrugBank) and 63 diseases |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Gastric acid secretion |
Digoxin Digoxin 💬Gastric acid secretion
| Digoxin | 002 [7] 2 , 8 , 46, 57, 65, 67, 210 💬76. Gastric acid secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 77 | Hematopoietic cell lineage 💬 47 genes, 97 drugs (DrugBank) and 101 diseases |
MME [1] MME 💬Hematopoietic cell lineage
|
Sacubitril Sacubitril 💬Hematopoietic cell lineage
| Sacubitril | 028 [4] 28, 58, 210, 222 💬77. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||
| 78 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Hormone signaling
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬78. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||
| 79 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Hormone signaling
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬78. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||
| 80 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
AGTR1 [1] AGTR1 💬Hormone signaling
|
Valsartan Valsartan 💬Hormone signaling
| Valsartan | 028 [11] 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬80. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||
| 81 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
AVPR1A [3] AVPR1A, AVPR1B, AVPR2 💬
|
Vasopressin Vasopressin 💬Hormone signaling
| Vasopressin | 210 [2] 210, 225 💬
|
||||||||||||||||||||||||||||||||||||||||||||
| 82 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine sodium Liothyronine sodium 💬Hormone signaling
| Liothyronine | 013 [3] 13, 210, 212 💬82. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||
| 83 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine Liothyronine 💬Hormone signaling
| Liothyronine | 013 [3] 13, 210, 212 💬82. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||
| 84 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
PTGS2 [1] PTGS2 💬Human cytomegalovirus infection
|
Aspirin Aspirin 💬Human cytomegalovirus infection
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬84. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||
| 85 | Human papillomavirus infection 💬 52 genes, 114 drugs (DrugBank) and 121 diseases |
PTGS2 [1] PTGS2 💬Human papillomavirus infection
|
Aspirin Aspirin 💬Human papillomavirus infection
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬85. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||||||||
| 86 | Huntington disease 💬 26 genes, 42 drugs (DrugBank) and 91 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Huntington disease
|
Colchicine Colchicine 💬Huntington disease
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬86. Huntington disease
|
||||||||||||||||||||||||||||||||||||||||||||
| 87 | Hypertrophic cardiomyopathy 💬 26 genes, 57 drugs (DrugBank) and 97 diseases |
ACE [1] ACE 💬Hypertrophic cardiomyopathy
|
Enalapril maleate Enalapril maleate 💬Hypertrophic cardiomyopathy
| Enalapril | 013 [10] 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬87. Hypertrophic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||
| 88 | Hypertrophic cardiomyopathy 💬 26 genes, 57 drugs (DrugBank) and 97 diseases |
ACE [1] ACE 💬Hypertrophic cardiomyopathy
|
Enalapril Enalapril 💬Hypertrophic cardiomyopathy
| Enalapril | 013 [10] 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬87. Hypertrophic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||
| 89 | IgSF CAM signaling 💬 45 genes, 68 drugs (DrugBank) and 91 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬IgSF CAM signaling
|
Colchicine Colchicine 💬IgSF CAM signaling
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬89. IgSF CAM signaling
|
||||||||||||||||||||||||||||||||||||||||||||
| 90 | IL-17 signaling pathway 💬 20 genes, 65 drugs (DrugBank) and 91 diseases |
PTGS2 [1] PTGS2 💬IL-17 signaling pathway
|
Aspirin Aspirin 💬IL-17 signaling pathway
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬90. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 91 | Insulin secretion 💬 16 genes, 51 drugs (DrugBank) and 61 diseases |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Insulin secretion |
Digoxin Digoxin 💬Insulin secretion
| Digoxin | 002 [7] 2 , 8 , 46, 57, 65, 67, 210 💬91. Insulin secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 92 | Kaposi sarcoma-associated herpesvirus infection 💬 61 genes, 102 drugs (DrugBank) and 124 diseases |
PTGS2 [1] PTGS2 💬Kaposi sarcoma-associated herpesvirus infection
|
Aspirin Aspirin 💬Kaposi sarcoma-associated herpesvirus infection
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬92. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||||||
| 93 | Leishmaniasis 💬 40 genes, 76 drugs (DrugBank) and 105 diseases |
PTGS2 [1] PTGS2 💬Leishmaniasis
|
Aspirin Aspirin 💬Leishmaniasis
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬93. Leishmaniasis
|
||||||||||||||||||||||||||||||||||||||||||||
| 94 | Melanogenesis 💬 7 genes, 18 drugs (DrugBank) and 34 diseases |
EDNRB [1] EDNRB 💬Melanogenesis
|
Bosentan Bosentan 💬Melanogenesis
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬94. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||||||||
| 95 | Melanogenesis 💬 7 genes, 18 drugs (DrugBank) and 34 diseases |
EDNRB [1] EDNRB 💬Melanogenesis
|
Bosentan Bosentan 💬Melanogenesis
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬94. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||||||||
| 96 | Melanogenesis 💬 7 genes, 18 drugs (DrugBank) and 34 diseases |
EDNRB [1] EDNRB 💬Melanogenesis
|
Macitentan Macitentan 💬Melanogenesis
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬96. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||||||||
| 97 | MicroRNAs in cancer 💬 32 genes, 78 drugs (DrugBank) and 96 diseases |
PTGS2 [1] PTGS2 💬MicroRNAs in cancer
|
Aspirin Aspirin 💬MicroRNAs in cancer
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬97. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||||||||||||
| 98 | Mineral absorption 💬 8 genes, 14 drugs (DrugBank) and 35 diseases |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Mineral absorption |
Digoxin Digoxin 💬Mineral absorption
| Digoxin | 002 [7] 2 , 8 , 46, 57, 65, 67, 210 💬98. Mineral absorption
|
||||||||||||||||||||||||||||||||||||||||||||
| 99 | Motor proteins 💬 25 genes, 10 drugs (DrugBank) and 21 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Motor proteins
|
Colchicine Colchicine 💬Motor proteins
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬99. Motor proteins
|
||||||||||||||||||||||||||||||||||||||||||||
| 100 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Neuroactive ligand signaling
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬100. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||
| 101 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Neuroactive ligand signaling
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬100. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||
| 102 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Neuroactive ligand-receptor interaction
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬102. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||
| 103 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Neuroactive ligand-receptor interaction
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬102. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||
| 104 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
AGTR1 [1] AGTR1 💬Neuroactive ligand-receptor interaction
|
Valsartan Valsartan 💬Neuroactive ligand-receptor interaction
| Valsartan | 028 [11] 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬104. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||
| 105 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
AVPR1A [3] AVPR1A, AVPR1B, AVPR2 💬
|
Vasopressin Vasopressin 💬Neuroactive ligand-receptor interaction
| Vasopressin | 210 [2] 210, 225 💬
|
||||||||||||||||||||||||||||||||||||||||||||
| 106 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
EDNRA [1] EDNRA 💬Neuroactive ligand-receptor interaction
|
Ambrisentan Ambrisentan 💬Neuroactive ligand-receptor interaction
| Ambrisentan | 051 [10] 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬106. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||
| 107 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Neuroactive ligand-receptor interaction
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬107. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||
| 108 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Neuroactive ligand-receptor interaction
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬107. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||
| 109 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Macitentan Macitentan 💬Neuroactive ligand-receptor interaction
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬109. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||
| 110 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
PTGIR [1] PTGIR 💬Neuroactive ligand-receptor interaction
|
Treprostinil Treprostinil 💬Neuroactive ligand-receptor interaction
| Treprostinil | 051 [6] 51, 84, 85, 86, 88, 210 💬110. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||
| 111 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
PTGIR [1] PTGIR 💬Neuroactive ligand-receptor interaction
|
Treprostinil monosodium salt Treprostinil monosodium salt 💬Neuroactive ligand-receptor interaction
| Treprostinil | 051 [6] 51, 84, 85, 86, 88, 210 💬110. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||
| 112 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
PTGIR [1] PTGIR 💬Neuroactive ligand-receptor interaction
|
Treprostinil diolamine Treprostinil diolamine 💬Neuroactive ligand-receptor interaction
| Treprostinil | 051 [6] 51, 84, 85, 86, 88, 210 💬110. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||
| 113 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine sodium Liothyronine sodium 💬Neuroactive ligand-receptor interaction
| Liothyronine | 013 [3] 13, 210, 212 💬113. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||
| 114 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine Liothyronine 💬Neuroactive ligand-receptor interaction
| Liothyronine | 013 [3] 13, 210, 212 💬113. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||
| 115 | NF-kappa B signaling pathway 💬 23 genes, 81 drugs (DrugBank) and 97 diseases |
PTGS2 [1] PTGS2 💬NF-kappa B signaling pathway
|
Aspirin Aspirin 💬NF-kappa B signaling pathway
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬115. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 116 | Ovarian steroidogenesis 💬 7 genes, 40 drugs (DrugBank) and 53 diseases |
PTGS2 [1] PTGS2 💬Ovarian steroidogenesis
|
Aspirin Aspirin 💬Ovarian steroidogenesis
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬116. Ovarian steroidogenesis
|
||||||||||||||||||||||||||||||||||||||||||||
| 117 | Oxytocin signaling pathway 💬 34 genes, 85 drugs (DrugBank) and 112 diseases |
PTGS2 [1] PTGS2 💬Oxytocin signaling pathway
|
Aspirin Aspirin 💬Oxytocin signaling pathway
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬117. Oxytocin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 118 | Pancreatic secretion 💬 18 genes, 46 drugs (DrugBank) and 56 diseases |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Pancreatic secretion |
Digoxin Digoxin 💬Pancreatic secretion
| Digoxin | 002 [7] 2 , 8 , 46, 57, 65, 67, 210 💬118. Pancreatic secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 119 | Parkinson disease 💬 24 genes, 73 drugs (DrugBank) and 71 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Parkinson disease
|
Colchicine Colchicine 💬Parkinson disease
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬119. Parkinson disease
|
||||||||||||||||||||||||||||||||||||||||||||
| 120 | Pathogenic Escherichia coli infection 💬 31 genes, 46 drugs (DrugBank) and 84 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Pathogenic Escherichia coli infection
|
Colchicine Colchicine 💬Pathogenic Escherichia coli infection
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬120. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||||||||||||
| 121 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
AGTR1 [1] AGTR1 💬Pathways in cancer
|
Valsartan Valsartan 💬Pathways in cancer
| Valsartan | 028 [11] 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬121. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||
| 122 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
EDNRA [1] EDNRA 💬Pathways in cancer
|
Ambrisentan Ambrisentan 💬Pathways in cancer
| Ambrisentan | 051 [10] 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬122. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||
| 123 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Pathways in cancer
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬123. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||
| 124 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Pathways in cancer
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬123. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||
| 125 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Macitentan Macitentan 💬Pathways in cancer
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬125. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||
| 126 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
PTGS2 [1] PTGS2 💬Pathways in cancer
|
Aspirin Aspirin 💬Pathways in cancer
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬126. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||
| 127 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
PTGS2 [1] PTGS2 💬Pathways of neurodegeneration - multiple diseases
|
Aspirin Aspirin 💬Pathways of neurodegeneration - multiple diseases
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬127. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||
| 128 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Pathways of neurodegeneration - multiple diseases
|
Colchicine Colchicine 💬Pathways of neurodegeneration - multiple diseases
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬128. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||
| 129 | Phagocytosis 💬 44 genes, 34 drugs (DrugBank) and 43 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Phagocytosis
|
Colchicine Colchicine 💬Phagocytosis
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬129. Phagocytosis
|
||||||||||||||||||||||||||||||||||||||||||||
| 130 | Phospholipase D signaling pathway 💬 24 genes, 60 drugs (DrugBank) and 84 diseases |
AGTR1 [1] AGTR1 💬Phospholipase D signaling pathway
|
Valsartan Valsartan 💬Phospholipase D signaling pathway
| Valsartan | 028 [11] 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬130. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 131 | Phospholipase D signaling pathway 💬 24 genes, 60 drugs (DrugBank) and 84 diseases |
AVPR1A [3] AVPR1A, AVPR1B, AVPR2 💬
|
Vasopressin Vasopressin 💬Phospholipase D signaling pathway
| Vasopressin | 210 [2] 210, 225 💬
|
||||||||||||||||||||||||||||||||||||||||||||
| 132 | Platelet activation 💬 24 genes, 72 drugs (DrugBank) and 66 diseases |
PTGIR [1] PTGIR 💬Platelet activation
|
Treprostinil Treprostinil 💬Platelet activation
| Treprostinil | 051 [6] 51, 84, 85, 86, 88, 210 💬132. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||||||
| 133 | Platelet activation 💬 24 genes, 72 drugs (DrugBank) and 66 diseases |
PTGIR [1] PTGIR 💬Platelet activation
|
Treprostinil monosodium salt Treprostinil monosodium salt 💬Platelet activation
| Treprostinil | 051 [6] 51, 84, 85, 86, 88, 210 💬132. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||||||
| 134 | Platelet activation 💬 24 genes, 72 drugs (DrugBank) and 66 diseases |
PTGIR [1] PTGIR 💬Platelet activation
|
Treprostinil diolamine Treprostinil diolamine 💬Platelet activation
| Treprostinil | 051 [6] 51, 84, 85, 86, 88, 210 💬132. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||||||
| 135 | Platelet activation 💬 24 genes, 72 drugs (DrugBank) and 66 diseases |
PTGS1 [1] PTGS1 💬Platelet activation
|
Aspirin Aspirin 💬Platelet activation
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬135. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||||||
| 136 | Prion disease 💬 41 genes, 77 drugs (DrugBank) and 121 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Prion disease
|
Colchicine Colchicine 💬Prion disease
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬136. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||
| 137 | Protein digestion and absorption 💬 15 genes, 12 drugs (DrugBank) and 21 diseases |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Protein digestion and absorption |
Digoxin Digoxin 💬Protein digestion and absorption
| Digoxin | 002 [7] 2 , 8 , 46, 57, 65, 67, 210 💬137. Protein digestion and absorption
|
||||||||||||||||||||||||||||||||||||||||||||
| 138 | Protein digestion and absorption 💬 15 genes, 12 drugs (DrugBank) and 21 diseases |
MME [1] MME 💬Protein digestion and absorption
|
Sacubitril Sacubitril 💬Protein digestion and absorption
| Sacubitril | 028 [4] 28, 58, 210, 222 💬138. Protein digestion and absorption
|
||||||||||||||||||||||||||||||||||||||||||||
| 139 | Proximal tubule bicarbonate reclamation 💬 7 genes, 6 drugs (DrugBank) and 21 diseases |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Proximal tubule bicarbonate reclamation |
Digoxin Digoxin 💬Proximal tubule bicarbonate reclamation
| Digoxin | 002 [7] 2 , 8 , 46, 57, 65, 67, 210 💬139. Proximal tubule bicarbonate reclamation
|
||||||||||||||||||||||||||||||||||||||||||||
| 140 | Purine metabolism 💬 30 genes, 44 drugs (DrugBank) and 82 diseases |
PDE5A [1] PDE5A 💬Purine metabolism
|
Sildenafil citrate Sildenafil citrate 💬Purine metabolism
| Sildenafil | 006 [17] 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬140. Purine metabolism
|
||||||||||||||||||||||||||||||||||||||||||||
| 141 | Purine metabolism 💬 30 genes, 44 drugs (DrugBank) and 82 diseases |
PDE5A [1] PDE5A 💬Purine metabolism
|
Sildenafil Sildenafil 💬Purine metabolism
| Sildenafil | 006 [17] 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬140. Purine metabolism
|
||||||||||||||||||||||||||||||||||||||||||||
| 142 | Purine metabolism 💬 30 genes, 44 drugs (DrugBank) and 82 diseases |
PDE5A [1] PDE5A 💬Purine metabolism
|
Tadalafil Tadalafil 💬Purine metabolism
| Tadalafil | 006 [8] 6 , 51, 75, 77, 84, 86, 113, 210 💬142. Purine metabolism
|
||||||||||||||||||||||||||||||||||||||||||||
| 143 | Purine metabolism 💬 30 genes, 44 drugs (DrugBank) and 82 diseases |
PDE5A [1] PDE5A 💬Purine metabolism
|
Udenafil Udenafil 💬Purine metabolism
| Udenafil | 086 [2] 86, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||
| 144 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
ADRB1 [2] ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Regulation of lipolysis in adipocytes
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬144. Regulation of lipolysis in adipocytes
|
||||||||||||||||||||||||||||||||||||||||||||
| 145 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
ADRB1 [2] ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Regulation of lipolysis in adipocytes
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬144. Regulation of lipolysis in adipocytes
|
||||||||||||||||||||||||||||||||||||||||||||
| 146 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
PTGS1 [2] PTGS1, PTGS2 💬
|
Aspirin Aspirin 💬Regulation of lipolysis in adipocytes
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬146. Regulation of lipolysis in adipocytes
|
||||||||||||||||||||||||||||||||||||||||||||
| 147 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 53 diseases |
EDNRB [1] EDNRB 💬Relaxin signaling pathway
|
Bosentan Bosentan 💬Relaxin signaling pathway
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬147. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 148 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 53 diseases |
EDNRB [1] EDNRB 💬Relaxin signaling pathway
|
Bosentan Bosentan 💬Relaxin signaling pathway
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬147. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 149 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 53 diseases |
EDNRB [1] EDNRB 💬Relaxin signaling pathway
|
Macitentan Macitentan 💬Relaxin signaling pathway
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬149. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 150 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ACE [1] ACE 💬Renin secretion
|
Enalapril maleate Enalapril maleate 💬Renin secretion
| Enalapril | 013 [10] 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬150. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 151 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ACE [1] ACE 💬Renin secretion
|
Enalapril Enalapril 💬Renin secretion
| Enalapril | 013 [10] 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬150. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 152 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ADRB1 [2] ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Renin secretion
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬152. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 153 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ADRB1 [2] ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Renin secretion
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬152. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 154 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
AGTR1 [1] AGTR1 💬Renin secretion
|
Valsartan Valsartan 💬Renin secretion
| Valsartan | 028 [11] 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬154. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 155 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
EDNRA [1] EDNRA 💬Renin secretion
|
Ambrisentan Ambrisentan 💬Renin secretion
| Ambrisentan | 051 [10] 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬155. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 156 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
EDNRA [1] EDNRA 💬Renin secretion
|
Bosentan Bosentan 💬Renin secretion
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬156. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 157 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
EDNRA [1] EDNRA 💬Renin secretion
|
Bosentan Bosentan 💬Renin secretion
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬156. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 158 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
EDNRA [1] EDNRA 💬Renin secretion
|
Macitentan Macitentan 💬Renin secretion
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬158. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 159 | Renin-angiotensin system 💬 6 genes, 22 drugs (DrugBank) and 33 diseases |
ACE [1] ACE 💬Renin-angiotensin system
|
Enalapril maleate Enalapril maleate 💬Renin-angiotensin system
| Enalapril | 013 [10] 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬159. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||
| 160 | Renin-angiotensin system 💬 6 genes, 22 drugs (DrugBank) and 33 diseases |
ACE [1] ACE 💬Renin-angiotensin system
|
Enalapril Enalapril 💬Renin-angiotensin system
| Enalapril | 013 [10] 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬159. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||
| 161 | Renin-angiotensin system 💬 6 genes, 22 drugs (DrugBank) and 33 diseases |
AGTR1 [1] AGTR1 💬Renin-angiotensin system
|
Valsartan Valsartan 💬Renin-angiotensin system
| Valsartan | 028 [11] 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬161. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||
| 162 | Renin-angiotensin system 💬 6 genes, 22 drugs (DrugBank) and 33 diseases |
MME [1] MME 💬Renin-angiotensin system
|
Sacubitril Sacubitril 💬Renin-angiotensin system
| Sacubitril | 028 [4] 28, 58, 210, 222 💬162. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||
| 163 | Retrograde endocannabinoid signaling 💬 34 genes, 70 drugs (DrugBank) and 74 diseases |
PTGS2 [1] PTGS2 💬Retrograde endocannabinoid signaling
|
Aspirin Aspirin 💬Retrograde endocannabinoid signaling
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬163. Retrograde endocannabinoid signaling
|
||||||||||||||||||||||||||||||||||||||||||||
| 164 | Salivary secretion 💬 20 genes, 75 drugs (DrugBank) and 75 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Salivary secretion
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬164. Salivary secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 165 | Salivary secretion 💬 20 genes, 75 drugs (DrugBank) and 75 diseases |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Salivary secretion
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬164. Salivary secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 166 | Salivary secretion 💬 20 genes, 75 drugs (DrugBank) and 75 diseases |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Salivary secretion |
Digoxin Digoxin 💬Salivary secretion
| Digoxin | 002 [7] 2 , 8 , 46, 57, 65, 67, 210 💬166. Salivary secretion
|
||||||||||||||||||||||||||||||||||||||||||||
| 167 | Salmonella infection 💬 32 genes, 48 drugs (DrugBank) and 78 diseases |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Salmonella infection
|
Colchicine Colchicine 💬Salmonella infection
| Colchicine | 002 [9] 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬167. Salmonella infection
|
||||||||||||||||||||||||||||||||||||||||||||
| 168 | Serotonergic synapse 💬 40 genes, 130 drugs (DrugBank) and 89 diseases |
PTGS1 [2] PTGS1, PTGS2 💬
|
Aspirin Aspirin 💬Serotonergic synapse
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬168. Serotonergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||
| 169 | Small cell lung cancer 💬 15 genes, 47 drugs (DrugBank) and 63 diseases |
PTGS2 [1] PTGS2 💬Small cell lung cancer
|
Aspirin Aspirin 💬Small cell lung cancer
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬169. Small cell lung cancer
|
||||||||||||||||||||||||||||||||||||||||||||
| 170 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 62 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Pravastatin sodium Pravastatin sodium 💬Terpenoid backbone biosynthesis
| Pravastatin | 013 [11] 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬170. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||
| 171 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 62 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Pravastatin Pravastatin 💬Terpenoid backbone biosynthesis
| Pravastatin | 013 [11] 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬170. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||
| 172 | Thyroid hormone signaling pathway 💬 25 genes, 46 drugs (DrugBank) and 78 diseases |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Thyroid hormone signaling pathway |
Digoxin Digoxin 💬Thyroid hormone signaling pathway
| Digoxin | 002 [7] 2 , 8 , 46, 57, 65, 67, 210 💬172. Thyroid hormone signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 173 | Thyroid hormone signaling pathway 💬 25 genes, 46 drugs (DrugBank) and 78 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine sodium Liothyronine sodium 💬Thyroid hormone signaling pathway
| Liothyronine | 013 [3] 13, 210, 212 💬173. Thyroid hormone signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 174 | Thyroid hormone signaling pathway 💬 25 genes, 46 drugs (DrugBank) and 78 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine Liothyronine 💬Thyroid hormone signaling pathway
| Liothyronine | 013 [3] 13, 210, 212 💬173. Thyroid hormone signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 175 | Thyroid hormone synthesis 💬 7 genes, 11 drugs (DrugBank) and 11 diseases |
ATP1A1 [4] ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Thyroid hormone synthesis |
Digoxin Digoxin 💬Thyroid hormone synthesis
| Digoxin | 002 [7] 2 , 8 , 46, 57, 65, 67, 210 💬175. Thyroid hormone synthesis
|
||||||||||||||||||||||||||||||||||||||||||||
| 176 | TNF signaling pathway 💬 25 genes, 64 drugs (DrugBank) and 95 diseases |
PTGS2 [1] PTGS2 💬TNF signaling pathway
|
Aspirin Aspirin 💬TNF signaling pathway
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬176. TNF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||
| 177 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
ADRA1A [3] ADRA1A, ADRA1B, ADRA1D 💬
|
Carvedilol Carvedilol 💬Vascular smooth muscle contraction
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬177. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||
| 178 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
ADRA1A [3] ADRA1A, ADRA1B, ADRA1D 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Vascular smooth muscle contraction
| Carvedilol | 006 [7] 6 , 46, 57, 58, 86, 113, 210 💬177. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||
| 179 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
AGTR1 [1] AGTR1 💬Vascular smooth muscle contraction
|
Valsartan Valsartan 💬Vascular smooth muscle contraction
| Valsartan | 028 [11] 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬179. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||
| 180 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
AVPR1A [2] AVPR1A, AVPR1B 💬
|
Vasopressin Vasopressin 💬Vascular smooth muscle contraction
| Vasopressin | 210 [2] 210, 225 💬
|
||||||||||||||||||||||||||||||||||||||||||||
| 181 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
EDNRA [1] EDNRA 💬Vascular smooth muscle contraction
|
Ambrisentan Ambrisentan 💬Vascular smooth muscle contraction
| Ambrisentan | 051 [10] 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬181. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||
| 182 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
EDNRA [1] EDNRA 💬Vascular smooth muscle contraction
|
Bosentan Bosentan 💬Vascular smooth muscle contraction
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬182. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||
| 183 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
EDNRA [1] EDNRA 💬Vascular smooth muscle contraction
|
Bosentan Bosentan 💬Vascular smooth muscle contraction
| Bosentan | 013 [12] 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬182. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||
| 184 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
EDNRA [1] EDNRA 💬Vascular smooth muscle contraction
|
Macitentan Macitentan 💬Vascular smooth muscle contraction
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬184. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||
| 185 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
PTGIR [1] PTGIR 💬Vascular smooth muscle contraction
|
Treprostinil Treprostinil 💬Vascular smooth muscle contraction
| Treprostinil | 051 [6] 51, 84, 85, 86, 88, 210 💬185. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||
| 186 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
PTGIR [1] PTGIR 💬Vascular smooth muscle contraction
|
Treprostinil monosodium salt Treprostinil monosodium salt 💬Vascular smooth muscle contraction
| Treprostinil | 051 [6] 51, 84, 85, 86, 88, 210 💬185. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||
| 187 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
PTGIR [1] PTGIR 💬Vascular smooth muscle contraction
|
Treprostinil diolamine Treprostinil diolamine 💬Vascular smooth muscle contraction
| Treprostinil | 051 [6] 51, 84, 85, 86, 88, 210 💬185. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||
| 188 | Vasopressin-regulated water reabsorption 💬 1 gene, 6 drugs (DrugBank) and 13 diseases |
AVPR2 [1] AVPR2 💬Vasopressin-regulated water reabsorption
|
Vasopressin Vasopressin 💬Vasopressin-regulated water reabsorption
| Vasopressin | 210 [2] 210, 225 💬
|
||||||||||||||||||||||||||||||||||||||||||||
| 189 | VEGF signaling pathway 💬 22 genes, 58 drugs (DrugBank) and 94 diseases |
PTGS2 [1] PTGS2 💬VEGF signaling pathway
|
Aspirin Aspirin 💬VEGF signaling pathway
| Acetylsalicylic acid | 013 [5] 13, 46, 51, 62, 210 💬189. VEGF signaling pathway
|
Adrenergic signaling in cardiomyocytes
31 genes, 86 drugs (DrugBank) and 81 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 58 drugs (DrugBank) and 100 diseases
Aldosterone synthesis and secretion
20 genes, 43 drugs (DrugBank) and 63 diseases
Aldosterone-regulated sodium reabsorption
13 genes, 17 drugs (DrugBank) and 34 diseases
Alzheimer disease
59 genes, 136 drugs (DrugBank) and 139 diseases
AMPK signaling pathway
16 genes, 58 drugs (DrugBank) and 100 diseases
Amyotrophic lateral sclerosis
39 genes, 58 drugs (DrugBank) and 116 diseases
Apelin signaling pathway
18 genes, 37 drugs (DrugBank) and 81 diseases
Arachidonic acid metabolism
5 genes, 29 drugs (DrugBank) and 46 diseases
Bile secretion
13 genes, 36 drugs (DrugBank) and 66 diseases
C-type lectin receptor signaling pathway
28 genes, 71 drugs (DrugBank) and 108 diseases
Calcium signaling pathway
82 genes, 215 drugs (DrugBank) and 140 diseases
cAMP signaling pathway
67 genes, 191 drugs (DrugBank) and 133 diseases
Carbohydrate digestion and absorption
13 genes, 22 drugs (DrugBank) and 40 diseases
Cardiac muscle contraction
17 genes, 21 drugs (DrugBank) and 34 diseases
cGMP-PKG signaling pathway
48 genes, 132 drugs (DrugBank) and 123 diseases
Chagas disease
32 genes, 59 drugs (DrugBank) and 88 diseases
Chemical carcinogenesis - DNA adducts
1 gene, 26 drugs (DrugBank) and 43 diseases
Chemical carcinogenesis - receptor activation
41 genes, 140 drugs (DrugBank) and 133 diseases
Complement and coagulation cascades
21 genes, 46 drugs (DrugBank) and 60 diseases
Coronavirus disease
56 genes, 115 drugs (DrugBank) and 109 diseases
Cortisol synthesis and secretion
15 genes, 39 drugs (DrugBank) and 63 diseases
Cushing syndrome
23 genes, 56 drugs (DrugBank) and 71 diseases
Cytoskeleton in muscle cells
26 genes, 19 drugs (DrugBank) and 17 diseases
Diabetic cardiomyopathy
25 genes, 48 drugs (DrugBank) and 80 diseases
Dilated cardiomyopathy
23 genes, 61 drugs (DrugBank) and 93 diseases
Efferocytosis
30 genes, 78 drugs (DrugBank) and 97 diseases
Endocrine and other factor-regulated calcium reabsorption
9 genes, 31 drugs (DrugBank) and 50 diseases
Gap junction
27 genes, 103 drugs (DrugBank) and 87 diseases
Gastric acid secretion
14 genes, 54 drugs (DrugBank) and 63 diseases
Hematopoietic cell lineage
47 genes, 97 drugs (DrugBank) and 101 diseases
Hormone signaling
64 genes, 217 drugs (DrugBank) and 150 diseases
Human cytomegalovirus infection
65 genes, 121 drugs (DrugBank) and 136 diseases
Human papillomavirus infection
52 genes, 114 drugs (DrugBank) and 121 diseases
Huntington disease
26 genes, 42 drugs (DrugBank) and 91 diseases
Hypertrophic cardiomyopathy
26 genes, 57 drugs (DrugBank) and 97 diseases
IgSF CAM signaling
45 genes, 68 drugs (DrugBank) and 91 diseases
IL-17 signaling pathway
20 genes, 65 drugs (DrugBank) and 91 diseases
Insulin secretion
16 genes, 51 drugs (DrugBank) and 61 diseases
Kaposi sarcoma-associated herpesvirus infection
61 genes, 102 drugs (DrugBank) and 124 diseases
Leishmaniasis
40 genes, 76 drugs (DrugBank) and 105 diseases
Melanogenesis
7 genes, 18 drugs (DrugBank) and 34 diseases
MicroRNAs in cancer
32 genes, 78 drugs (DrugBank) and 96 diseases
Mineral absorption
8 genes, 14 drugs (DrugBank) and 35 diseases
Motor proteins
25 genes, 10 drugs (DrugBank) and 21 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 118 diseases
Neuroactive ligand-receptor interaction
156 genes, 371 drugs (DrugBank) and 171 diseases
NF-kappa B signaling pathway
23 genes, 81 drugs (DrugBank) and 97 diseases
Ovarian steroidogenesis
7 genes, 40 drugs (DrugBank) and 53 diseases
Oxytocin signaling pathway
34 genes, 85 drugs (DrugBank) and 112 diseases
Pancreatic secretion
18 genes, 46 drugs (DrugBank) and 56 diseases
Parkinson disease
24 genes, 73 drugs (DrugBank) and 71 diseases
Pathogenic Escherichia coli infection
31 genes, 46 drugs (DrugBank) and 84 diseases
Pathways in cancer
116 genes, 235 drugs (DrugBank) and 150 diseases
Pathways of neurodegeneration - multiple diseases
64 genes, 143 drugs (DrugBank) and 141 diseases
Phagocytosis
44 genes, 34 drugs (DrugBank) and 43 diseases
Phospholipase D signaling pathway
24 genes, 60 drugs (DrugBank) and 84 diseases
Platelet activation
24 genes, 72 drugs (DrugBank) and 66 diseases
Prion disease
41 genes, 77 drugs (DrugBank) and 121 diseases
Protein digestion and absorption
15 genes, 12 drugs (DrugBank) and 21 diseases
Proximal tubule bicarbonate reclamation
7 genes, 6 drugs (DrugBank) and 21 diseases
Purine metabolism
30 genes, 44 drugs (DrugBank) and 82 diseases
Regulation of lipolysis in adipocytes
13 genes, 72 drugs (DrugBank) and 80 diseases
Relaxin signaling pathway
23 genes, 34 drugs (DrugBank) and 53 diseases
Renin secretion
28 genes, 90 drugs (DrugBank) and 108 diseases
Renin-angiotensin system
6 genes, 22 drugs (DrugBank) and 33 diseases
Retrograde endocannabinoid signaling
34 genes, 70 drugs (DrugBank) and 74 diseases
Salivary secretion
20 genes, 75 drugs (DrugBank) and 75 diseases
Salmonella infection
32 genes, 48 drugs (DrugBank) and 78 diseases
Serotonergic synapse
40 genes, 130 drugs (DrugBank) and 89 diseases
Small cell lung cancer
15 genes, 47 drugs (DrugBank) and 63 diseases
Terpenoid backbone biosynthesis
4 genes, 14 drugs (DrugBank) and 62 diseases
Thyroid hormone signaling pathway
25 genes, 46 drugs (DrugBank) and 78 diseases
Thyroid hormone synthesis
7 genes, 11 drugs (DrugBank) and 11 diseases
TNF signaling pathway
25 genes, 64 drugs (DrugBank) and 95 diseases
Vascular smooth muscle contraction
32 genes, 95 drugs (DrugBank) and 74 diseases
Vasopressin-regulated water reabsorption
1 gene, 6 drugs (DrugBank) and 13 diseases
VEGF signaling pathway
22 genes, 58 drugs (DrugBank) and 94 diseases
